Concepedia

Yongzi Xu

YX

Statistics

Publications

3

Citations

93

H-Index

3

Active since

2020

Affiliations

Jiangsu Cancer Hospital(Current)

Nanjing Medical University

Yongzi Xu is an author at Jiangsu Cancer Hospital specializing in tumor biology, cancer research, and gene expression.

ORCID

Top concepts

Publications per year

2020–2025

3

Publications

3

Long non‑coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR‑675

Yongzi Xu, Yanhui Liu, Zhenrong Li et al. · Oncology Reports · 2020 · 44 citations · Full text

, , +20

UBE2S promotes cell chemoresistance through PTEN-AKT signaling in hepatocellular carcinoma

Liang Gui, Si‐Cai Zhang, Yongzi Xu et al. · Cell Death Discovery · 2021 · 36 citations · Full text

Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial

Tao Ma, Xueli Bai, Qi Zhang et al. · Hepatology · 2025 · 13 citations

1–3 of 3